SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-015989
Filing Date
2017-08-07
Accepted
2017-08-07 16:12:08
Documents
51
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20170630.htm 10-Q 2796123
2 EX-31.1 fgen-ex311_8.htm EX-31.1 8272
3 EX-31.2 fgen-ex312_9.htm EX-31.2 8266
4 EX-32.1 fgen-ex321_6.htm EX-32.1 7481
  Complete submission text file 0001564590-17-015989.txt   8019649

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fgen-20170630.xml EX-101.INS 1914521
6 XBRL TAXONOMY EXTENSION SCHEMA fgen-20170630.xsd EX-101.SCH 37127
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20170630_cal.xml EX-101.CAL 52728
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20170630_def.xml EX-101.DEF 109996
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20170630_lab.xml EX-101.LAB 283842
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20170630_pre.xml EX-101.PRE 226766
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 171011625
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences